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SUMMARY 
 
This study analysed the influence of several factors affecting the consolidation time of 
83 massive bone allografts in. 79 patients with malignant bone tumours: osteosarcoma 
57; Evving's sarcoma 8; malignant fibrous histiocytoma 3; chondrosarcoma 4; 
fibrosarcoma 5; and giant cell tumours 2. The mean age of the patients was 19 years and 
the mean length of the allografts was 18 cm. The minimum follow up was for 12 
months. The mean consolidation time for metaphyseal and diaphyseal osteotomies was 
6.5 and 16 months respectively. Fifteen diaphyseal osteotomies required autologous 
cancellous grafting. There were 8 allograft fractures after consolidation. The following 
factors which might influence consolidation were analysed: age of the host and donor; 
allograft length and site; type of osteotomy and osteosynthesis; intra-arterial and 
systemic chemotherapy; intraoperative and external radiotherapy. In diaphyseal 
osteotomies there were statistically significant differences in consolidation time with the 
use of systemic chemotherapy, external radiotherapy and the recipient's age. 
 
 
RÉSUMÉ 
 
Dans le present travail, est analysé le temps de consolidation et les facteurs qui ont pu 
l'influencer de 83 allogreffes corticospongieuses placées chez 79 patients affectés de 
tumeurs osseuses primitives malignes (57 ostéosarcomes, 8 sarcomes d'Ewing, 3 HFM, 
4 chondrosarcomes, 5 fibrosarcomes et 2 TCG), traités par chirurgie conservatrice, avec 
un age compris entre 4 et 69 ans (ni = 19). La durée moyenne de consolidation fut 6.5 
mois pour les ostéotomies métaphysaires, 16 pour les diaphysaires, avec 1 
pseudarthrose métaphysaire et 7 diaphysaires. Quinze allogreffes ont eu besoin d'un 
apport de greffe autologue pour consolider et 8 eurent une fracture une fois consolidé. 
On a analysé les différents facteurs qui ont pu influencer la consolidation; âge du 
donneur et du receveur; longueur et localisation de rallogreffe, type d'ostéotomie et 
d'ostéosynthése, chimiothérapie (intra-artèrielle ou systémique) et radiothérapie 
(intraopératoire ou externe). Dans les ostéotomies diaphysaires, la chimiothérapie 
systémique (p < 0.05), la radiothérapie externe (p < 0.01) et l'age du receveur (p < 0.01) 
retardent la consolidation. 
 
 
 
 
 
 
 
INTRODUCTION 
 
En bloc resection of all macroscopic disease is necessary in the treatment of primary 
bone tumours, and the two main surgical procedures are amputation and limb-
preserving reconstruction. The development of modern limb-preserving operations [1, 
10, 11, 14, 24, 26, 44] has been helped by the introduction of new diagnostic methods 
[32], the widespread use of preoperative chemotherapy [4, 42, 43, 44], radiotherapy [6, 
7, 8] and multiagent adjuvant chemotherapy [6, 7, 10, 18, 25, 29, 30, 32, 33, 35, 45]. 
 
Reconstructive surgery with massive allografts has been possible with the development 
of bone banks [2, 17] and provides a successful alternative to a prosthetic implant in 
young patients who have a long life expectancy. Allografts offer many advantages 
compared to metallic implants including joint reconstruction, incorporation of the graft 
to the host bone, and longevity [18]. There are, however, problems such as the 
cryopreservation of articular cartilage and articular denervation which may lead to a 
situation similar to neuropathic arthropathy when osteoarticular allografts are used [11]. 
 
Since 1987 we have used more than 150 massive allografts in the conservative 
management of malignant bone tumours. The purpose of this study is to analyse the 
factors which might influence the time for consolidation of these allografts. 
 
 
PATIENTS AND METHODS 
 
We reviewed the first 100 allografts which we had used in limb-preserving operations 
for bone tumours. We excluded those tumours occurring in the axial skeleton, patients 
with less than one year's follow up and those who failed to attend. We included 83 
allografts implanted in 79 patients; the allograft was removed because of infection in 4, 
and a second allograft implanted more than a year after the original operation. The 
histological diagnoses of the resected specimens are shown in Table 1. 
 
Preoperative staging was made after conventional radiography, digitalised angiography, 
radionucleide scan, CT scan, MRI and biopsy, which was usually by percutaneous 
aspiration. We did not take into account Enneking's criteria [16] regarding intra- or 
extracompartmental involvement. Radiographs and a CT scan of the lungs were used to 
rule out metastases. 
  
Allografts were removed under sterile conditions from cadavers following the 
guidelines of the American Association of Tissue Banks [17]. Laboratory tests included 
culture for anaerobic and aerobic bacteria, VDRL, B and C hepatitis and HIV. 
 
En bloc resection, including the biopsy scar, was carried out for primary nonmetastatic 
tumours. The level of the osteotomy was determined by the intramedullary spread as 
shown by CT and MRI. Our safe margin was 5 cm and we performed intraoperative 
biopsy of the resected margins. Every patient was given prophylactic cephalosporin. 
Chemotherapy and radiotherapy was used in every case following the University Clinic 
of Navarra Cancer Protocol [42, 43], depending on the type of tumour. Table 2 shows 
the protocol for osteosarcoma. The disease-free survival with the protocol for 
osteosarcoma is 74.4% at 5 years and 70.3% at 10 years (Kaplan-Meier). Table 3 shows 
the antitumour treatment given. 
The type of allograft depended on the involvement of the growth plate and the 
possibility of preserving the joint near the tumour. We implanted 35 endoprostheses into 
a fresh-frozen allograft (Fig. 1) and carried out 29 intercalary allografts, 15 
osteoarticular allografts (Fig. 2a, b), and 4 arthrodeses with corticocancellous allografts. 
 
The mean length of the allografts was 18 cm (range 4 to 42 cm) (Fig. 3 a, b). The mean 
age of the group was 19.6 years (range 4 to 69 years). The mean follow up was 33.7 
months (range 12 to 82 months). 
 
The follow up was at monthly intervals during the first year of systemic chemotherapy, 
with diagnostic studies being made to assess the local and systemic control of the 
disease. Subsequently, the follow up was 3 monthly for another year, and then every 6 
months. 
 
We studied the consolidation of 80 diaphyseal and 32 metaphyseal osteotomies (Table 
4). Metaphyseal osteotomies were horizontal in all but one case, and several types of 
osteosynthesis were used including Kirschner wires, Ender nails, screws and staples 
(Table 5). 
  
The ISOLS criteria were used to evaluate the consolidation results (Table 6). We 
considered the age of the host and donor, allograft length and location, type of 
osteotomy and osteosynthesis, infra-arterial and systemic chemotherapy, intraoperative 
and external radiotherapy. We used multi-variant statistical analysis with the Statview 
programme and the functional results were rated according to Mankin's classification 
[33]. 
 
 
RESULTS 
 
The mean consolidation time for metaphyseal osteotomies was 6.5 months and we did 
not find any statistically significant correlation with the factors we studied. There was 
only one malunion, in a patient in whom a tibial allograft was used in an ankle 
arthrodesis, which had no clinical significance. Consolidation was achieved in many 
cases with minimal osteosynthesis. 
 
The mean consolidation time for diaphyseal osteotomies was 16 months. There were 
statistically significant differences with the use of systemic chemotherapy (p < 0.05) 
and the use of external radiotherapy (p < 0.01) with both factors delaying consolidation. 
The older the patient the worse was the influence on consolidation (p < 0.01). 
 
There were no statistically significant differences with the use of intra-arterial 
chemotherapy, intraoperative radiotherapy, the donor's age, the type of osteosynthesis 
(plates vs intramedullary devices), the type of osteotomy (horizontal vs oblique) or the 
type and site of the tumour. 
 
Seven (8.7%) diaphyseal nonunions occurred. Further osteosynthesis and autogenous 
iliac bone grafting was needed in 15 diaphyseal osteotomies. Most of the osteosyntheses 
were with plates. In order to avoid a large implant some used in children were 
inadequate. There were 8 (9.6%) allograft fractures, 4 of which consolidated with 
conventional treatment. 
DISCUSSION 
 
Metaphyseal osteotomies consolidated at a mean time of 6 months which is similar to 
Vander Griend's findings [49]. The mean consolidation time for diaphyseal osteotomies 
in his series was 9 months, but he did not give the criteria for determining consolidation, 
Mankin reported 18 months [30], and in our series the time was 16 months. Seventy-
three out of 79 of our patients had chemotherapy, whereas in the other two series [30, 
49] almost half the patients did not. We believe that chemotherapy plays an important 
part in delaying consolidation. We found statistically significant differences between 
those who had intensive adjuvant chemotherapy for a year after the operation and those 
who had not. Our finding is supported by data in other series [12, 13, 20, 31, 44]. 
Radiological changes have been seen in the long bones of patients who have had 
chemotherapy without irradiation [44], and Shinohara found that all grafted bone in 
patients receiving chemotherapy failed to heal primarily [46]. Glasser reported slowing 
of growth during the year of intensive chemotherapy given to children with 
osteosarcoma and Ewing's tumour [20]. Experimental studies have also proved that 
chemotherapeutic agents impair bone healing and that allogenic cortical bone grafts 
incorporate more slowly when chemotherapy is given [27, 52]. 
 
External radiation also delayed consolidation and ionising radiation is known to have a 
harmful effect on skeletal growth [15, 21, 23, 33, 46, 47, 48] which results from 
alterations of chondroblastic [21, 40] and periosteal activity [41]. Radiation also 
damages the small and medium blood vessels supplying nutrients to the bone, reducing 
the potential for healing [21]. Retardation of bone growth caused by irradiation is dose-
dependent [5, 22, 36, 50]. Clinically measurable growth disturbance can be produced by 
doses below 500 cGy [5]. Computed tomographic-assisted planning systems and 
increasingly sophisticated therapy equipment may help to reduce the side effects of 
radiation. 
 
Intra-arterial chemotherapy and intraoperative radiotherapy did not influence graft 
consolidation since both are given before the graft is implanted and do not cause 
sufficient soft tissue damage to delay bony healing. 
 
Our incidence of nonunion was similar to that reported in other series [18, 30, 34, 35, 
49]. Seven of 8 nonunions occurred at diaphyseal osteotomies. The routine addition of 
autogenous bone graft at the allograft-host junction has been advocated when the graft 
is implanted [3, 51], but we only used autogenous graft in patients with delayed 
consolidation to avoid morbidity from the donor site. 
 
We thought that oblique osteotomies would heal more quickly than transverse due to the 
larger contact area [53]. However, we did not find any statistically significant difference 
in the consolidation time between the 2 types. We now only use an oblique osteotomy 
to avoid rotation when using non-locked intramedullary systems. 
 
We prefer to use intramedullary devices for fixation as they allow weightbearing 
immediately after operation [28, 49] in contrast to plates. Plate fixation was associated 
with a higher incidence of fracture of the allograft [49] and with the need for further 
osteosynthesis, particularly in children when we used minimal fixation. 
 
Some authors advise replacement after fracture through the shaft of the allograft 
because of the limited potential for healing of the graft, but we were able to achieve 
consolidation in these circumstances with conventional treatment, as has been reported 
by others [47]. 
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Table 1. Histological diagnosis 
Histological diagnosis No. 
Osteosarcoma  
Osteoblastic 36 
Chondroblastic 11 
Fibroblastic 6 
Telangiectasic 2 
Parosteal 2 
Ewing's sarcoma 8 
Fibrosarcoma of bone 5 
Chondrosarcoma 4 
Malignant fibrous histiocytoma of bone 3 
Aggresive giant cell tumour 2 
Total 79 
 
 
 
Table 2. Therapeutic protocol for osteosarcoma in our Department 
1. 1. Neoadjuvant chemotherapy:  
2. CDPP: 40 mg/m
2
IAx3 days, every 3 weeks for 3 cycles  
3. ADR: 30 mg/m
2
IVx2 days, every 3 weeks for 3 cycles  
4. MTX: 8 mg/m
2
IV/days 7, 14, 29 and 36 
2. Surgery 
3. Postoperative chemotherapy (9 to 12 months): MTX, CDPP, ADR, bleomycin,       
actinomicin D, cyclophosphamide and vincristine 
 
 
 
 
Table 3. Antitumour therapy 
Systemic chemotherapy 73 
External radiotherapy 24 
Intraoperative radiotherapy 53 
Intra-arterial chemotherapy 57 
 
 
 
 
 
 
Table 4 
Allografts 83 
Patients 79 
Metaphyseal osteotomy only 3 
Diaphyseal osteotomy only (TKR, some osteoarticular allografts, etc) 51 
Metaphyseal and diaphyseal osteotomy (intercalary allografts) 29 
 
 
 
Table 5. Diaphyseal osteotomies and osteosynthesis 
Osteotomy  
Horizontal 46 
Oblique 34 
Osteosynthesis  
Plates 42 
Intramedullary 38 
 
 
 
Table 6. ISOLS criteria for the fusion of allografts 
Excellent: fusion with osteotomy line not visible 
Good: fusion > 75% with osteotomy line still visible 
Fair: fusion 25-75% 
Poor: no evidence of callus or fusion <25% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. An endoprosthesis has been inserted into a fresh frozen allograft of the right 
distal femur with excellent consolidation. 
 
 
 
 
Figure 2. a Osteosarcoma of the distal end of the humerus. b Osteoarticular allograft of 
the elbow with a perforation for muscle attachment. Consolidation was at 3 months 
which was the fastest in the series. 
 
 
Figure 3. a Osteosarcoma involving almost the whole of the right femur with a skip 
metastasis in the distal metaphysis. b An osteoarticular allograft 42 cm long (the longest 
in the series) was inserted from the proximal epiphysis to the distal metaphysis. 
Consolidation of the metaphyseal osteotomy occurred in 6 months. 
